DJ Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ advanced 2.38% to $490.39 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.21% to 7,428.78 and the Dow Jones Industrial Average rising 1.03% to 52,747.32.
This was the stock's fourth consecutive day of gains.
Vertex Pharmaceuticals Inc. closed 8.11% below its 52-week high of $533.67, which the company achieved on July 7th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as AbbVie Inc. $(ABBV)$ rose 2.45% to $263.20, Krystal Biotech Inc. (KRYS) rose 3.53% to $364.23, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 0.17% to $5.75.
Data source: Dow Jones Market Data, FactSet. Data compiled July 28, 2026.
Comments